Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
暂无分享,去创建一个
[1] D. Nixon,et al. Expansion in CD39+ CD4+ Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications , 2013, PLoS neglected tropical diseases.
[2] M. Keramati,et al. Is there any relationship between expressions of minor blood group antigens with HTLV-I infection? , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[3] M. Azarpazhooh,et al. The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran , 2012, Journal of Neuroimmunology.
[4] M. Azarpazhooh,et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. , 2012, AIDS research and human retroviruses.
[5] A. Muniz,et al. Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP , 2012, Case reports in neurological medicine.
[6] K. Ogawa,et al. CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. , 2012, Academic radiology.
[7] Y. Yamano,et al. Clinical Pathophysiology of Human T-Lymphotropic Virus-Type 1-Associated Myelopathy/Tropical Spastic Paraparesis , 2012, Front. Microbio..
[8] F. Kashanchi,et al. HTLV Tax: A Fascinating Multifunctional Co-Regulator of Viral and Cellular Pathways , 2012, Front. Microbio..
[9] G. Mufti,et al. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL). , 2012, Leukemia research.
[10] H. Rafatpanah,et al. Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[11] A. Duarte,et al. Detection of human T-cell lymphotropic virus type 1 in plasma samples. , 2012, Virus research.
[12] V. Soriano,et al. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain , 2012, Virology Journal.
[13] M. Azarpazhooh,et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] R. Nasr,et al. Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects? , 2011, Viruses.
[15] ナシュワ ハゼイン アブデルバリー リスク. Reduced Tim-3 expression on human T-lymphotropic virus type I(HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection , 2011 .
[16] G. Vanham,et al. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: Influence of clinical status, sex, and familial relatedness , 2006, Journal of NeuroVirology.
[17] K. Yamaguchi,et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.
[18] M. Saito,et al. Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) , 2010, Interdisciplinary perspectives on infectious diseases.
[19] E. Wattel,et al. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). , 2009, Blood.
[20] A. Duarte,et al. Low DNA HTLV-2 proviral load among women in São Paulo City. , 2008, Virus research.
[21] R. Gallo. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2 , 2005, Oncogene.
[22] P. Korkolopoulou,et al. Adult T-Cell Leukemia/Lymphoma (ATLL): Report of Two Fully Documented Hellenic Patients , 2004, Leukemia & lymphoma.
[23] Società Italiana di Emaferesi. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , 2001 .
[24] B. Bain,et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. , 1999, Journal of acquired immune deficiency syndromes.
[25] M. Tomonaga,et al. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV‐1 genotype , 1999, British journal of haematology.
[26] S. Izumo,et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.
[27] S. Izumo,et al. Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp , 1998 .
[28] Shinsuke Suzuki,et al. Treatment for adult T-cell leukemia , 1997, Cancer Chemotherapy and Pharmacology.
[29] M. Greaves,et al. HTLV-I positive adult T-cell leukaemia/lymphoma (ATLL) in Chile. , 1994, Leukemia.